Abstract: This invention relates to a novel process for preparing 2-halogeno-nicotinic acids. The compounds, especially 2-chloro-nicotinic acid, are intermediates in the preparation of anilino nicotinic acid derivatives. The latter compounds are useful as analgesic anti-diarrheal and anti-inflammatory agents.
Abstract: A novel process for preparing novel 1-N-acyl-4,6-di-(aminoglycosyl)aminocyclitols is disclosed. The compounds are useful as antibacterial agents.
Abstract: A microorganism of the genus Actinoplanes produces a novel complex of polyene antibiotics herein designated collectively Antibiotic 67-121 (and sometimes referred to as the Antibiotic 67-121 complex). The individual components are designated Antibiotic 67-121A, Antibiotic 67-121B, Antibiotic 67-121C and Antibiotic 67-121D. The individual components have ultraviolet spectra characteristic of heptaenes. Further, they are orally active against a variety of strains of Candida albicans including many clinical isolates thereof.
Type:
Grant
Filed:
June 9, 1975
Date of Patent:
May 31, 1977
Assignee:
Schering Corporation
Inventors:
Marvin J. Weinstein, Gerald H. Wagman, Joseph A. Marquez, Mahesh G. Patel
Abstract: Described herein are novel monoesters of rosamicin, also known as Antibiotic 67-694. Also described is a process for the preparation of such esters by the selective solvolysis of diester precursors. The monoesters are broad spectrum antibacterial agents but are generally more effective against gram-positive bacteria.